GPT Healthcare: Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Along With Limited Review Report Of The Statutory Auditors Thereon Of The Company For The 3Rd Quarter And Nine Months (Q3 & 9MFY26) Ended December 31 2025.

GPT Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2026 inter alia to consider and approve the Unaudited Financial Results along with Limited Review Report of the Statutory Auditors thereon of the Company for the 3rd quarter and nine months (Q3 & 9MFY26) ended December 31 2025.